BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 17589201)

  • 1. The first reported case and management of multicentric Castleman's disease associated with Kaposi's sarcoma in an HIV-2-infected patient.
    Bouvresse S; Marcelin AG; Franck N; Regnier S; Damond F; Tulliez M; Dupin N
    AIDS; 2007 Jul; 21(11):1492-4. PubMed ID: 17589201
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclophosphamide/cyclosporin-A treatment of multicentric Castleman's disease with Kaposi's sarcoma.
    Bertero MT; De Maestri M; Caligaris-Cappio F
    Haematologica; 2000 Feb; 85(2):216-7. PubMed ID: 10681737
    [No Abstract]   [Full Text] [Related]  

  • 3. KSHV/HHV8-associated primary cutaneous plasmablastic lymphoma in a patient with Castleman's disease and Kaposi's sarcoma.
    Liu W; Lacouture ME; Jiang J; Kraus M; Dickstein J; Soltani K; Shea CR
    J Cutan Pathol; 2006 Sep; 33 Suppl 2():46-51. PubMed ID: 16972955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant and fatal HHV-8+ multicentric Castleman's disease and Kaposi's sarcoma in the same lymph node of an HIV- liver transplant patient.
    Gaitonde S; Vidanovic V; Ni H
    Histopathology; 2007 Jun; 50(7):954-8. PubMed ID: 17543090
    [No Abstract]   [Full Text] [Related]  

  • 5. Multicentric Castleman's disease in association with Kaposi's sarcoma.
    De Rosa G; Barra E; Guarino M; Gentile R
    Appl Pathol; 1989; 7(2):105-10. PubMed ID: 2730798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of rituximab in human immunodeficiency virus-associated multicentric Castleman disease.
    Neuville S; Agbalika F; Rabian C; Brière J; Molina JM
    Am J Hematol; 2005 Aug; 79(4):337-9. PubMed ID: 16044438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaposi's sarcoma-associated herpes virus and acquired immunodeficiency syndrome-related malignancy.
    Cannon M; Cesarman E
    Semin Oncol; 2000 Aug; 27(4):409-19. PubMed ID: 10950367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients.
    Oksenhendler E; Duarte M; Soulier J; Cacoub P; Welker Y; Cadranel J; Cazals-Hatem D; Autran B; Clauvel JP; Raphael M
    AIDS; 1996 Jan; 10(1):61-7. PubMed ID: 8924253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HHV-8 linked to Kaposi's sarcoma, Castleman's disease and primary effusion lymphoma in a HIV-1-infected man.
    Bestawros A; Boulassel MR; Michel RP; Routy JP
    J Clin Virol; 2008 Jun; 42(2):179-81. PubMed ID: 18343194
    [No Abstract]   [Full Text] [Related]  

  • 10. Absence of Kaposi's sarcoma associated herpesvirus-like DNA sequences (KSHV) in HIV-negative multicentric Castleman's disease complicated by KSHV-positive Kaposi's sarcoma.
    Kwong YL; Chan AC
    Br J Haematol; 1997 Mar; 96(4):881-2. PubMed ID: 9074443
    [No Abstract]   [Full Text] [Related]  

  • 11. An unusual cluster of cases of Castleman's disease during highly active antiretroviral therapy for AIDS.
    Zietz C; Bogner JR; Goebel FD; Löhrs U
    N Engl J Med; 1999 Jun; 340(24):1923-4. PubMed ID: 10375310
    [No Abstract]   [Full Text] [Related]  

  • 12. Castleman disease in an HIV-infected patient with Kaposi sarcoma.
    Saif MW
    AIDS Read; 2001 Nov; 11(11):572-6. PubMed ID: 11789020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
    Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
    Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of rituximab as a salvage therapy for HIV-associated multicentric Castleman disease.
    Casquero A; Barroso A; Fernández Guerrero ML; Górgolas M
    Ann Hematol; 2006 Mar; 85(3):185-7. PubMed ID: 16341862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's sarcoma of lymph nodes associated with multicentric angiofollicular hyperplasia.
    Leoncini L; del Vecchio MT; Minacci C; Pieragalli D; Monaci A
    Appl Pathol; 1989; 7(5):329-32. PubMed ID: 2635620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient.
    Murphy C; Hawkes E; Chionh F; Chong G
    J Clin Pharm Ther; 2017 Feb; 42(1):111-114. PubMed ID: 27790727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fulminant HHV-8 associated Castleman's disease in a non-HIV, Kaposi sarcoma patient with borderline hemophagocytic syndrome.
    Barbarov I; Koren-Michowitz M; Schiby G; Portnoy O; Livingstone D; Segal G
    Isr Med Assoc J; 2015 Apr; 17(4):253-5. PubMed ID: 26040056
    [No Abstract]   [Full Text] [Related]  

  • 18. [Two HHV8-related illnesses in a HIV-negative patient: Kaposi's sarcoma and multicentric Castleman's disease. Response to treatment with Rituximab and CHOP].
    Pastor MA; Vasco B; Mosquera JM; Debén G; Bautista P; Requena L
    Actas Dermosifiliogr; 2006; 97(6):385-90. PubMed ID: 16956518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human herpesvirus 8 DNA in HIV-negative Japanese patients with multicentric Castleman's disease and related diseases.
    Tohda S; Murakami N; Nara N
    Int J Mol Med; 2001 Nov; 8(5):549-51. PubMed ID: 11605026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's sarcoma biology.
    Boshoff C
    IUBMB Life; 2002; 53(4-5):259-61. PubMed ID: 12121006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.